文献
J-GLOBAL ID:201702214953174281
整理番号:17A1437617
以前に初回化学療法としてのR-CHOP療法を受けたびまん性大細胞型B細胞リンパ腫患者に対するリツキシマブ,メチルプレドニソロン,イホスファミド,メトトレキセート,エトポシド,およびカルボプラチンのR P IMVP16/CBDCAのサルベージ化学療法【Powered by NICT】
A salvage chemotherapy of R-P-IMVP16/CBDCA consisting of rituximab, methylprednisolone, ifosfamide, methotrexate, etoposide, and carboplatin for patients with diffuse large B cell lymphoma who had previously received R-CHOP therapy as first-line chemotherapy
著者 (18件):
Matsumoto Takuro
(Department of Hematology, Gifu University Graduate School of Medicine, Gifu, Japan)
,
Hara Takeshi
(Department of Hematology, Gifu University Graduate School of Medicine, Gifu, Japan)
,
Shibata Yuhei
(Department of Hematology, Gifu University Graduate School of Medicine, Gifu, Japan)
,
Nakamura Nobuhiko
(Department of Hematology, Gifu University Graduate School of Medicine, Gifu, Japan)
,
Nakamura Hiroshi
(Department of Hematology, Gifu University Graduate School of Medicine, Gifu, Japan)
,
Ninomiya Soranobu
(Department of Hematology, Gifu University Graduate School of Medicine, Gifu, Japan)
,
Kitagawa Junichi
(Department of Hematology, Gifu University Graduate School of Medicine, Gifu, Japan)
,
Kanemura Nobuhiro
(Department of Hematology, Gifu University Graduate School of Medicine, Gifu, Japan)
,
Goto Naoe
(Department of Hematology, Gifu University Graduate School of Medicine, Gifu, Japan)
,
Kito Yusuke
(Department of Pathology and Translational Research, Gifu University Graduate School of Medicine, Gifu, Japan)
,
Kasahara Senji
(Department of Hematology, Gifu Municipal Hospital, Gifu, Japan)
,
Yamada Toshiki
(Department of Hematology, Gifu Prefectural General Medical Center, Gifu, Japan)
,
Sawada Michio
(Department of Hematology, Japanese Red Cross Gifu Hospital, Gifu, Japan)
,
Miyazaki Tatsuhiko
(Pathology Division, Gifu University Hospital, Gifu, Japan)
,
Takami Tsuyoshi
(Department of Pathology and Translational Research, Gifu University Graduate School of Medicine, Gifu, Japan)
,
Takeuchi Tamotsu
(Department of Pathology and Translational Research, Gifu University Graduate School of Medicine, Gifu, Japan)
,
Moriwaki Hisataka
(Department of Hematology, Gifu University Graduate School of Medicine, Gifu, Japan)
,
Tsurumi Hisashi
(Department of Hematology, Gifu University Graduate School of Medicine, Gifu, Japan)
資料名:
Hematological Oncology
(Hematological Oncology)
巻:
35
号:
3
ページ:
288-295
発行年:
2017年
JST資料番号:
D0357E
ISSN:
0278-0232
CODEN:
HAONDL
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)